Your browser doesn't support javascript.
loading
Developmental Pathway of the MPER-Directed HIV-1-Neutralizing Antibody 10E8.
Soto, Cinque; Ofek, Gilad; Joyce, M Gordon; Zhang, Baoshan; McKee, Krisha; Longo, Nancy S; Yang, Yongping; Huang, Jinghe; Parks, Robert; Eudailey, Joshua; Lloyd, Krissey E; Alam, S Munir; Haynes, Barton F; Mullikin, James C; Connors, Mark; Mascola, John R; Shapiro, Lawrence; Kwong, Peter D.
Afiliação
  • Soto C; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Ofek G; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Joyce MG; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Zhang B; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • McKee K; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Longo NS; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Yang Y; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Huang J; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland United States of America.
  • Parks R; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina United States of America.
  • Eudailey J; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina United States of America.
  • Lloyd KE; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina United States of America.
  • Alam SM; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina United States of America.
  • Haynes BF; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina United States of America.
  • Mullikin JC; NIH Intramural Sequencing Center, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland United States of America.
  • Connors M; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland United States of America.
  • Mascola JR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Shapiro L; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Kwong PD; Department of Biochemistry and Molecular Biophysics, Columbia University, New York, United States of America.
PLoS One ; 11(6): e0157409, 2016.
Article em En | MEDLINE | ID: mdl-27299673
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Anti-HIV / Proteína gp41 do Envelope de HIV / Infecções por HIV / HIV-1 / Anticorpos Neutralizantes Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Anti-HIV / Proteína gp41 do Envelope de HIV / Infecções por HIV / HIV-1 / Anticorpos Neutralizantes Idioma: En Ano de publicação: 2016 Tipo de documento: Article